Pieris Pharmaceuticals, Inc.

The current price of PIRS is 0.17 USD — it has decreased by 1.35% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pieris Pharmaceuticals, Inc. stocks are traded under the ticker PIRS.

Pieris Pharmaceuticals, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

PIRS earnings for the last quarter are −0.18 USD whereas the estimation was −0.18 USD which accounts for 1.88% surprise. Estimated earnings for the next quarter are −0.16 USD. See more details about Pieris Pharmaceuticals, Inc. earnings.

Yes, you can track Pieris Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, PIRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pieris Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

PIRS reached its all-time high on Feb 13, 2018 with the price of 9.75 USD, and its all-time low was 0.14 USD and was reached on Dec 13, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 16, 2024, the company has 50.00 employees. See our rating of the largest employees — is Pieris Pharmaceuticals, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pieris Pharmaceuticals, Inc. EBITDA is ‪−14.06 M‬ USD, and current EBITDA margin is −32.85%. See more stats in Pieris Pharmaceuticals, Inc. financial statements.